Hepatology International最新文献

筛选
英文 中文
Converging pathways: the interaction between estimated glucose disposal rate and atherogenic index of plasma in MASLD risk stratification. 收敛路径:MASLD风险分层中估计葡萄糖处置率与血浆动脉粥样硬化指数的相互作用
IF 7.8 2区 医学
Hepatology International Pub Date : 2026-10-01 Epub Date: 2026-05-25 DOI: 10.1007/s12072-026-11098-0
Mingxing Chang, Peipu Shen, Guifang Shen
{"title":"Converging pathways: the interaction between estimated glucose disposal rate and atherogenic index of plasma in MASLD risk stratification.","authors":"Mingxing Chang, Peipu Shen, Guifang Shen","doi":"10.1007/s12072-026-11098-0","DOIUrl":"10.1007/s12072-026-11098-0","url":null,"abstract":"<p><strong>Background: </strong>Metabolic dysfunction-associated steatotic liver disease (MASLD) is a global health burden linked to insulin resistance and atherogenic dyslipidemia, estimated by the glucose disposal rate (eGDR) and atherogenic index of plasma (AIP), respectively. However, the nature of their combined association-whether additive or interactive-with MASLD risk, and its utility for risk stratification, remains unexplored.</p><p><strong>Methods: </strong>In this large-scale cross-sectional analysis of 30,143 adults, we calculated eGDR and AIP from routine clinical measures. Their independent and joint associations with ultrasonography-defined MASLD were assessed using multivariable logistic regression, restricted cubic splines (RCS), and interaction analysis. Based on RCS-derived thresholds, participants were categorized into four metabolic phenotypes for combined risk assessment.</p><p><strong>Results: </strong>Both lower eGDR and higher AIP were independently and nonlinearly associated with greater MASLD risk (p for trend < 0.001). A significant interaction was observed (p < 0.001), revealing a convergent pattern: the protective association of high eGDR appeared attenuated as AIP increased, and the risk disparity attributable to AIP narrowed markedly at low eGDR levels. Participants with the combined low-eGDR/high-AIP phenotype had the highest MASLD odds (OR = 3.42, 95% CI 3.07-3.81). These findings were robust to alternative adjustment strategies and phenotype definitions in sensitivity analyses.</p><p><strong>Conclusions: </strong>eGDR and AIP exhibit a significant interactive association with MASLD risk, characterized by a convergent pattern: the incremental risk associated with atherogenic dyslipidemia (high AIP) appeared less pronounced under conditions of severe insulin resistance (low eGDR). Integrating these two metrics identifies a distinct high-risk phenotype and may inform future risk stratification strategies. Longitudinal studies are needed to establish causality and clinical utility.</p>","PeriodicalId":12901,"journal":{"name":"Hepatology International","volume":" ","pages":"1340-1352"},"PeriodicalIF":7.8,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13676677/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148015191","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Alcohol and dementia: is hepatic steatosis an innocent bystander or an active contributor to cognitive decline? 酒精和痴呆:肝脂肪变性是认知能力下降的无辜旁观者还是积极贡献者?
IF 7.8 2区 医学
Hepatology International Pub Date : 2026-10-01 Epub Date: 2026-09-09 DOI: 10.1007/s12072-026-11149-6
Cameron Gofton, Elie Matar, Jacob George
{"title":"Alcohol and dementia: is hepatic steatosis an innocent bystander or an active contributor to cognitive decline?","authors":"Cameron Gofton, Elie Matar, Jacob George","doi":"10.1007/s12072-026-11149-6","DOIUrl":"10.1007/s12072-026-11149-6","url":null,"abstract":"","PeriodicalId":12901,"journal":{"name":"Hepatology International","volume":" ","pages":"1295-1298"},"PeriodicalIF":7.8,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13676623/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148919199","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response to: "Refining Surgical Indications for Hepatocellular Carcinoma in Patients with Clinically Significant Portal Hypertension". 回应:“改进肝细胞癌临床显著门脉高压患者的手术指征”。
IF 7.8 2区 医学
Hepatology International Pub Date : 2026-10-01 Epub Date: 2025-11-28 DOI: 10.1007/s12072-025-10960-x
Yukihiro Watanabe, Masayasu Aikawa, Yoshiki Murase, Kenichiro Takase, Yuichiro Watanabe, Hiroaki Ono, Katsuya Okada, Kojun Okamoto, Isamu Koyama
{"title":"Response to: \"Refining Surgical Indications for Hepatocellular Carcinoma in Patients with Clinically Significant Portal Hypertension\".","authors":"Yukihiro Watanabe, Masayasu Aikawa, Yoshiki Murase, Kenichiro Takase, Yuichiro Watanabe, Hiroaki Ono, Katsuya Okada, Kojun Okamoto, Isamu Koyama","doi":"10.1007/s12072-025-10960-x","DOIUrl":"10.1007/s12072-025-10960-x","url":null,"abstract":"","PeriodicalId":12901,"journal":{"name":"Hepatology International","volume":" ","pages":"1506-1507"},"PeriodicalIF":7.8,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145632650","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on "Machine learning prediction of rapid HBsAg seroclearance at week 24 in inactive carriers treated with pegylated interferon". 对“使用聚乙二醇化干扰素治疗的无活性携带者在第24周快速HBsAg血清清除的机器学习预测”的评论。
IF 7.8 2区 医学
Hepatology International Pub Date : 2026-10-01 Epub Date: 2026-02-11 DOI: 10.1007/s12072-026-11042-2
Famei Xu
{"title":"Comment on \"Machine learning prediction of rapid HBsAg seroclearance at week 24 in inactive carriers treated with pegylated interferon\".","authors":"Famei Xu","doi":"10.1007/s12072-026-11042-2","DOIUrl":"10.1007/s12072-026-11042-2","url":null,"abstract":"","PeriodicalId":12901,"journal":{"name":"Hepatology International","volume":" ","pages":"1535-1536"},"PeriodicalIF":7.8,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146156977","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hidden structure, visible effects: uneven genotype missingness and its implications for interpreting Peg-IFN efficacy in CHB trials. 隐藏的结构,可见的效应:不均匀的基因型缺失及其对解释CHB试验中Peg-IFN疗效的影响
IF 7.8 2区 医学
Hepatology International Pub Date : 2026-10-01 Epub Date: 2026-02-28 DOI: 10.1007/s12072-026-11068-6
Binqi Wang, Danna Zheng, Jinshi Zhang
{"title":"Hidden structure, visible effects: uneven genotype missingness and its implications for interpreting Peg-IFN efficacy in CHB trials.","authors":"Binqi Wang, Danna Zheng, Jinshi Zhang","doi":"10.1007/s12072-026-11068-6","DOIUrl":"10.1007/s12072-026-11068-6","url":null,"abstract":"","PeriodicalId":12901,"journal":{"name":"Hepatology International","volume":" ","pages":"1551-1552"},"PeriodicalIF":7.8,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147321545","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correction: The Asian Pacific Association of the Study of the Liver expert survey on artificial intelligence-assisted reporting of liver histopathology in metabolic dysfunction associated fatty liver disease. 更正:亚太肝脏研究协会关于人工智能辅助报告代谢功能障碍相关脂肪肝的肝脏组织病理学的专家调查。
IF 7.8 2区 医学
Hepatology International Pub Date : 2026-10-01 DOI: 10.1007/s12072-026-11131-2
H Elangovan, K Akbary, A Rastogi, A Wee, G Soon, L Adams, E Carr-Boyd, A Clouston, C L Cooper, W K Chan, Y Y Dan, R Dela-Cruz, G Goh, S S Hamid, D Q Huang, T Kawaguchi, H Kim, W Kim, S U Kim, J D Jia, C J Liu, F Liu, W Q Leow, M D Muthiah, I Ng, D Payawal, A F Pan, S Pervez, G Shiha, T Tanwandee, Y Tanaka, L Thiyaphat, M Vij, Y Yilmaz, F Yilmaz, M L Yu, K Zalata, M H Zheng, J G Fan, S K Sarin, V Wong, J George
{"title":"Correction: The Asian Pacific Association of the Study of the Liver expert survey on artificial intelligence-assisted reporting of liver histopathology in metabolic dysfunction associated fatty liver disease.","authors":"H Elangovan, K Akbary, A Rastogi, A Wee, G Soon, L Adams, E Carr-Boyd, A Clouston, C L Cooper, W K Chan, Y Y Dan, R Dela-Cruz, G Goh, S S Hamid, D Q Huang, T Kawaguchi, H Kim, W Kim, S U Kim, J D Jia, C J Liu, F Liu, W Q Leow, M D Muthiah, I Ng, D Payawal, A F Pan, S Pervez, G Shiha, T Tanwandee, Y Tanaka, L Thiyaphat, M Vij, Y Yilmaz, F Yilmaz, M L Yu, K Zalata, M H Zheng, J G Fan, S K Sarin, V Wong, J George","doi":"10.1007/s12072-026-11131-2","DOIUrl":"10.1007/s12072-026-11131-2","url":null,"abstract":"","PeriodicalId":12901,"journal":{"name":"Hepatology International","volume":" ","pages":"1681-1683"},"PeriodicalIF":7.8,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13676662/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148812803","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on "Machine learning prediction of rapid HBsAg seroclearance at week 24 in inactive carriers treated with pegylated interferon". 对“使用聚乙二醇化干扰素治疗的无活性携带者在第24周快速HBsAg血清清除的机器学习预测”的评论。
IF 7.8 2区 医学
Hepatology International Pub Date : 2026-10-01 Epub Date: 2026-01-05 DOI: 10.1007/s12072-025-11010-2
Qiongying Xu, Jiehua Han, Jiali Zhu
{"title":"Comment on \"Machine learning prediction of rapid HBsAg seroclearance at week 24 in inactive carriers treated with pegylated interferon\".","authors":"Qiongying Xu, Jiehua Han, Jiali Zhu","doi":"10.1007/s12072-025-11010-2","DOIUrl":"10.1007/s12072-025-11010-2","url":null,"abstract":"","PeriodicalId":12901,"journal":{"name":"Hepatology International","volume":" ","pages":"1516-1517"},"PeriodicalIF":7.8,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145900183","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comment on "Autoimmune liver diseases in the Asia Pacific region: proceedings of the autoimmune liver disease course at APASL 2025". 对“亚太地区自身免疫性肝病:APASL 2025自身免疫性肝病课程论文集”的评论。
IF 7.8 2区 医学
Hepatology International Pub Date : 2026-10-01 Epub Date: 2026-02-25 DOI: 10.1007/s12072-026-11054-y
Bin Wu
{"title":"Comment on \"Autoimmune liver diseases in the Asia Pacific region: proceedings of the autoimmune liver disease course at APASL 2025\".","authors":"Bin Wu","doi":"10.1007/s12072-026-11054-y","DOIUrl":"10.1007/s12072-026-11054-y","url":null,"abstract":"","PeriodicalId":12901,"journal":{"name":"Hepatology International","volume":" ","pages":"1547-1548"},"PeriodicalIF":7.8,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147305028","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
APASL STC 2025 Tokyo. APASL STC 2025东京。
IF 7.8 2区 医学
Hepatology International Pub Date : 2026-10-01 DOI: 10.1007/s12072-026-11125-0
{"title":"APASL STC 2025 Tokyo.","authors":"","doi":"10.1007/s12072-026-11125-0","DOIUrl":"10.1007/s12072-026-11125-0","url":null,"abstract":"","PeriodicalId":12901,"journal":{"name":"Hepatology International","volume":" ","pages":"1561-1680"},"PeriodicalIF":7.8,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148792294","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pediatric autoimmune hepatitis in the Asia-Pacific region: practical considerations for guideline implementation. 亚太地区儿童自身免疫性肝炎:指南实施的实际考虑
IF 7.8 2区 医学
Hepatology International Pub Date : 2026-10-01 Epub Date: 2025-12-26 DOI: 10.1007/s12072-025-11005-z
Yimamujiang Aximu, Xuping Zhang, Peipei Zhang
{"title":"Pediatric autoimmune hepatitis in the Asia-Pacific region: practical considerations for guideline implementation.","authors":"Yimamujiang Aximu, Xuping Zhang, Peipei Zhang","doi":"10.1007/s12072-025-11005-z","DOIUrl":"10.1007/s12072-025-11005-z","url":null,"abstract":"","PeriodicalId":12901,"journal":{"name":"Hepatology International","volume":" ","pages":"1518-1519"},"PeriodicalIF":7.8,"publicationDate":"2026-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145833829","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书